Always consult a healthcare professional, especially if pregnant, breastfeeding, or managing a medical condition
The only problem lies with those who have genetic mutations that stop the metabolism or absorption of B12
The approval of the first oral GLP-1 weight loss pill by the FDA in December 2025 marks a major step forward in evidence-based obesity treatment
A 1,000mg standard capsule that causes nausea and is only 10% absorbed provides less value than a 250mg liposomal dose that is 90% absorbed and feels great in your system
That is what makes it different from most topical treatments, which address the surface of a specific area, or from peptides like BPC-157, which address a specific type of tissue damage
[7] GLP1R is composed of two domains, one extracellular (ECD) that binds the C-terminal helix of GLP-1, [8] and one transmembrane domain (TMD) [9] that binds the N-terminal region of GLP-1